Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 9.86% is 41% above its 5-year average of 7.00%, near the high end of its 5-year range (-1851.51%–39.84%).
165.35% above its 12-month average of -15.09%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -49.35%.
OPERATING MARGIN
9.86%
OPERATING MARGIN AVG TTM
-15.09%
OPERATING MARGIN AVG 3Y
9.33%
OPERATING MARGIN AVG 5Y
7.00%
OPERATING MARGIN AVG 10Y
-466.43%
OPERATING MARGIN AVG 15Y
-720.67%
OPERATING MARGIN AVG 20Y
-415.72%
CURRENT VS TTM AVG
+165.35%
CURRENT VS 3Y AVG
+5.69%
CURRENT VS 5Y AVG
+40.94%
CURRENT VS 10Y AVG
+102.11%
CURRENT VS 15Y AVG
+101.37%
CURRENT VS 20Y AVG
+102.37%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 748 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Gyre Therapeutics, Inc.
Market Cap
$792.69M
Operating Margin
9.86%
TTM Avg
-15.09%
3Y Avg
9.33%
5Y Avg
7.00%
Market Cap
$789.07M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
Market Cap
$796.60M
Operating Margin
-0.31%
TTM Avg
6.92%
3Y Avg
0.39%
5Y Avg
2.91%
Market Cap
$782.00M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$809.02M
Operating Margin
-7.86%
TTM Avg
-9.22%
3Y Avg
-47.88%
5Y Avg
-486.53%
Market Cap
$775.12M
Operating Margin
-98.21%
TTM Avg
-366.21%
3Y Avg
-21871.64%
5Y Avg
-19485.10%
Market Cap
$774.54M
Operating Margin
-4974.74%
TTM Avg
-2487.37%
3Y Avg
-2487.37%
5Y Avg
-2487.37%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | $792.69M | 9.86% | -15.09% | 9.33% | 7.00% |
| Apnimed, Inc. (APMD)vs › | $790.49M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $789.07M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| AdaptHealth Corp. (AHCO)vs › | $796.60M | -0.31% | 6.92% | 0.39% | 2.91% |
| Sana Biotechnology, Inc. (SANA)vs › | $782.00M | 0.00% | 0.00% | 0.00% | 0.00% |
| InMode Ltd. (INMD)vs › | $806.17M | 18.47% | 25.77% | 33.72% | 36.17% |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | -7.86% | -9.22% | -47.88% | -486.53% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.12M | -98.21% | -366.21% | -21871.64% | -19485.10% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.54M | -4974.74% | -2487.37% | -2487.37% | -2487.37% |
| Mesa Laboratories, Inc. (MLAB)vs › | $769.94M | 9.00% | 7.11% | -27.53% | -16.39% |
Gross Margin
94.3%
Operating Margin
9.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -49.35% |
| 2026-03-31 | -41.54% |
| 2025-12-31 | 0.32% |
| 2025-09-30 | 22.66% |
| 2025-06-30 | -7.53% |
| 2025-03-31 | 10.30% |
| 2024-12-31 | 2.38% |
| 2024-09-30 | 16.61% |
| 2024-06-30 | 12.93% |
| 2024-03-31 | 29.70% |
| 2023-12-31 | -337.53% |
| 2023-09-30 | 39.84% |
| 2023-06-30 | 16.96% |
| 2023-03-31 | 26.73% |
| 2022-12-31 | 16.16% |
| 2022-09-30 | 15.77% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -1851.51% |
| 2021-12-31 | -832.50% |
| 2021-09-30 | -1097.39% |
| 2021-06-30 | -1759.19% |
| 2021-03-31 | -1529.52% |
| 2020-12-31 | -927.67% |
| 2020-09-30 | -1802.91% |
| 2020-06-30 | -1047.10% |
| 2020-03-31 | -30.97% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 194733.33% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | -111316.67% |
| 2017-12-31 | -1833.02% |
| 2017-09-30 | -1848.43% |
| 2017-06-30 | -5354.95% |
| 2017-03-31 | -1539.11% |
| 2016-12-31 | -7352.11% |
| 2016-09-30 | -5240.37% |
| 2016-06-30 | -4509.17% |
| 2016-03-31 | -4194.50% |
| 2015-12-31 | -4297.25% |
| 2015-09-30 | -3564.22% |
| 2015-06-30 | -511.87% |
| 2015-03-31 | -1013.82% |
| 2014-12-31 | 1049.49% |
| 2014-09-30 | -19952.00% |
| 2014-06-30 | -22886.11% |
| 2014-03-31 | -13512.64% |
| 2013-12-31 | -14309.68% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | -233.99% |
| 2012-12-31 | -2755.93% |
| 2012-09-30 | -1054.43% |
| 2012-06-30 | 42.31% |
| 2012-03-31 | 8.69% |
| 2011-12-31 | -53.55% |
| 2011-09-30 | -49.23% |
| 2011-06-30 | -12.39% |
| 2011-03-31 | 31.55% |
| 2010-12-31 | -5.78% |
| 2010-09-30 | 11.09% |
| 2010-06-30 | 23.76% |
| 2010-03-31 | 36.32% |
| 2009-12-31 | -776.60% |
| 2009-09-30 | 9.51% |
| 2009-06-30 | -348.20% |
| 2009-03-31 | -82.27% |
| 2008-12-31 | -89.72% |
| 2008-09-30 | -149.83% |
| 2008-06-30 | -176.72% |
| 2008-03-31 | -167.86% |
| 2007-12-31 | -892722.32% |
| 2007-09-30 | -268.79% |
| 2007-06-30 | -319.17% |
| 2007-03-31 | -275.10% |
| 2006-12-31 | 65025.23% |
| 2006-09-30 | 4082.22% |
| 2006-06-30 | 6971280.81% |
| 2006-03-31 | 6746.27% |
| 2005-12-31 | -2838.03% |
| 2005-09-30 | -2119.38% |
| 2005-06-30 | -2783.03% |
| 2005-03-31 | -2524.93% |
